January 6th (Eastern Time) - $CERo Therapeutics (CERO.US)$ is about to implement a 1-for-100 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from January 8th, 2025.
$CERo Therapeutics (CERO.US)$ slipped 4.59% and closed at $0.0582 on January 3rd with a turnover of $3.33 million. $CERo Therapeutics (CERO.US)$ now has a total market capitalization of $11.16 million.
What Is a Reverse Stock Split?
A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.
Note:
The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.